Childhood cancer is a major global health issue. Every year, almost 100 000 children die
from cancer before the age of 15 years, more than 90% of them in resource-limited countries. …

Pan-cancer analyses that examine commonalities and differences among various cancer
types have emerged as a powerful way to obtain novel insights into cancer biology. Here we …

Seven years after the launch of the European Paediatric Medicine Regulation, limited
progress in paediatric oncology drug development remains a major concern amongst …

Historical risk stratification criteria for medulloblastoma rely primarily on clinicopathological
variables pertaining to age, presence of metastases, extent of resection, histological …

Background ECCO essential requirements for quality cancer care (ERQCC) are checklists
and explanations of organisation and actions that are necessary to give high-quality care to …

High-throughput genomic analyses may improve outcomes in patients with advanced cancers.
MOSCATO 01 is a prospective clinical trial evaluating the clinical benefit of this approach. …

Busulfan is known to be neurotoxic in animals and humans, but its acute neurotoxicity
remains poorly characterized in children. We report here a retrospective study of 123 children (…

Purpose: We used high-resolution oligonucleotide comparative genomic hybridization (CGH)
arrays and matching gene expression array data to identify dysregulated genes and to …

Background High-dose chemotherapy with haemopoietic stem-cell rescue improves event-free
survival in patients with high-risk neuroblastoma; however, which regimen has the …

The aim of the present study was to evaluate the tumor accumulation of radiolabeled long-circulating
poly(ethylene glycol) (PEG)-coated hexadecylcyanoacrylate nanospheres and non-…